ARCHIVES

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

US Files Motion To Dismiss Fisher Suit Over Database Flags

November 3, 1995

Anil Potti Explains: “Coming from India, I Did Not Know This Was Not The Real Rhodes Scholarship”

December 16, 2011

RFP Available; Program Announcement

April 16, 1993

FDA Approves Rituxan For CLL

February 19, 2010

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

NIH “Just In Time” Procedure Expanded For Two Awards

April 12, 1996